Nature, Published online: 23 November 2022; doi:10.1038/d41586-022-03767-5
Structural insights into a long-studied folate-transport protein provide evidence that might lead to entirely new targeted anticancer treatments, or boost the success of immunotherapy approaches to tackling tumours.
Source link